Font Size:
Site Colors:
Accesskey
S - Skip navigation
1 - Home page
4 - Search
Accessibility Statement

Introduction

The Rappaport Family Institute for Research in the Medical Sciences was founded in 1974, in partnership with the Technion, through the bold initiative and generous support of the Rappaport family.

The primary objective of the Rappaport Institute is to achieve scientific and academic excellence at the Faculty of Medicine through funding research and facilitating it, and thus promote the growth and development of both the Faculty and the Institute.

The promotion and facilitation of research at the Faculty of Medicine is realized through the continual funding of collaborative research programs, individual investigators and research infrastructure and by providing scientific, technical and administrative support at all levels.

In retrospect, the objective of the Rappaport Institute has been pursued with great success. Over the years, thanks to continual support of Rappaport family, leading edge research carried out at the Rappaport Institute and the Technion Faculty of Medicine contributed significantly to a deeper understanding of the complex inner workings of the human body, and has opened new doors toward treatments.  In fact, Mr. Bruce Rappaport predicted that these efforts would yield discoveries meriting recognition at the level of the Nobel Prize. Indeed, this courageous prediction became a reality, with the awarding of the 2004 Nobel Prize in Chemistry to Rappaport Institute and Faculty of Medicine members Professor Avram Hershko and Professor Aaron Ciechanover for the discovery of ubiquitin-mediated protein degradation.

Where the future is concerned, opportunities and challenges abound. The world of biomedical knowledge is undergoing explosive growth – both along traditional, detailed lines of study and along new avenues opened by the development of high throughput systems and the massive data sets these generate. Traditional borders between life sciences and medicine, on the one hand, and exact sciences and engineering on the other are breaking down. The profile of the bright and young scientists attracted to biomedical research is changing, with increasingly larger numbers of these arriving with strong backgrounds in physics, computer science and engineering. The expanded language, terminology and discourse are creating new and exciting opportunities for research, in particular within a world-class technological institution, and are spilling over into the education of physicians and research students alike. This broader discourse also presents challenges in terms of attracting and integrating individuals with appropriate interests and skills, providing them with necessary infrastructure, creating stimulating intellectual environments and connecting the Faculty of Medicine to its affiliated hospitals and to the engineering powerhouses in main Technion campus.

It is here where the Rappaport Institute has an incredibly important role to play, and it is a great honor for the Institute to take part in shaping this future.

Noam E. Ziv
Director

Name
Price
Quanity
Del.
Confirm and pay